Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14 Febbraio 2025 - 11:13PM
Edgar (US Regulatory)
JOINT FILING APPLICATION
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of ABVC BioPharma, Inc. shall be filed on behalf of each
of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
February 14, 2025
|
LIND GLOBAL FUND II LP
|
| |
|
By:
|
Lind Global Partners II LLC
|
| |
its General Partner
|
| |
|
|
By:
|
/s/ Jeff Easton
|
|
Name:
|
Jeff Easton
|
|
Title:
|
Managing Member
|
| |
|
|
LIND GLOBAL PARTNERS II LLC
|
| |
|
|
By:
|
/s/ Jeff Easton
|
|
Name:
|
Jeff Easton
|
|
Title:
|
Managing Member
|
| |
|
JEFF EASTON
|
| |
|
By:
|
|
|
Grafico Azioni ABVC BioPharma (NASDAQ:ABVC)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni ABVC BioPharma (NASDAQ:ABVC)
Storico
Da Mar 2024 a Mar 2025
